Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalid Mumtaz

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Transplantation Direct|October 17, 2022
Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!Abdul Wahab Dogar, Kaleem Ullah, Shams-Ud-Din, et al.
BMJ Open Gastroenterology|October 21, 2021
Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learnedAbdul Wahab Dogar, Shams Uddin, Abdul Ghaffar, et al.
The New England Journal of Medicine|March 3, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal SyndromeFlorence Wong, S Chris Pappas, Michael P Curry, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Transplantation Direct|October 17, 2022
Is a Preservation Solution for Living Donor Liver Transplantation Needed? Adding a New Chapter in LDLT!Abdul Wahab Dogar, Kaleem Ullah, Shams-Ud-Din, et al.
BMJ Open Gastroenterology|October 21, 2021
Challenges of continuation of live liver donor programme during COVID-19 pandemic in Pakistan: outcomes and lessons learnedAbdul Wahab Dogar, Shams Uddin, Abdul Ghaffar, et al.
The New England Journal of Medicine|March 3, 2021
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal SyndromeFlorence Wong, S Chris Pappas, Michael P Curry, et al.
Journal of Cancer Research and Clinical Oncology|September 7, 2022
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survivalAbdul Miah, Gabriel Tinoco, Songzhu Zhao, et al.
Pageof 13